US Stock MarketDetailed Quotes

ARVN Arvinas

Watchlist
  • 9.160
  • +0.090+0.99%
Trading Apr 24 12:38 ET
629.95MMarket Cap-3.31P/E (TTM)

About Arvinas Company

Arvinas, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer, ARV-471, and ARV-766, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company was founded in February 2013 and is headquartered in New Haven, CT.

Company Profile

SymbolARVN
Company NameArvinas
Listing DateSep 27, 2018
Issue Price16.00
Founded2013
CEODr. John G. Houston, PhD
MarketNASDAQ
Employees430
Fiscal Year Ends12-31
Address5 Science Park,395 Winchester Avenue
CityNew Haven
ProvinceConnecticut
CountryUnited States of America
Zip Code06511
Phone1-203-535-1456
Websitehttp://www.arvinas.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John G. Houston, PhD
  • Chairman of the Board, President and Chief Executive Officer
  • 7.63M
  • Dr. Noah Berkowitz, M.D.
  • Chief Medical Officer
  • --
  • Dr. Angela Cacace, PhD
  • Chief Scientific Officer
  • --
  • Randy Teel, PhD
  • Chief Business Officer
  • --
  • David Loomis
  • Vice President and Chief Accounting Officer
  • --
  • Andrew Saik
  • Chief Financial Officer and Treasurer
  • --
  • Dr. Ian Taylor, PhD
  • President, Research and Development
  • 2.73M
  • Linda C. Bain
  • Independent Director
  • 370.00K
  • Leslie V. Norwalk, Esq.
  • Independent Director
  • 350.00K
  • John Douglas Young
  • Independent Director
  • 422.49K
  • Everett V. Cunningham
  • Independent Director
  • 350.00K
  • Edward Kennedy, Jr
  • Independent Director
  • 345.41K
  • Dr. Sunil Agarwal, M.D.
  • Independent Director
  • 784.74K
  • Dr. Laurie Smaldone Alsup, M.D.
  • Independent Director
  • 430.30K
  • Dr. Briggs W. Morrison, M.D.
  • Lead Independent Director
  • 383.54K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 5.790
Sample Name
Sample Code
 70.390
Sample Name
Sample Code
 236.505
4
Teradata Corp
TDC
21.475
5
Ermenegildo Zegna NV
ZGN
7.680
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 186.990
Sample Name
Sample Code
 264.000
Sample Name
Sample Code
 146.980
4
Advanced Micro Devices
AMD
94.270
5
Netflix
NFLX
1093.430
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 9.962
Sample Name
Sample Code
 3.634
Sample Name
Sample Code
 0.4589
4
Argo Blockchain
ARBK
0.4099
5
TeraWulf
WULF
2.965
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -